Table 5 Summary of Median Overall Survivals in the various studies included in the current review
| Â | Â | Overall survival (months) | ||
|---|---|---|---|---|
| Â | Â | All patients | Resected | Not resected |
Resectable | Median (range) | 18.2 (13–28) | 30.0 (24.5–46) | 10 (9–11) |
| Â | n | 9 | 8 | 5 |
Borderline resectable | Median (range) | 19.2 (9.1–45) | 27.4 (19.3–41.2) | 12.9 (9–15.5) |
| Â | n | 11 | 8 | 7 |
Locally advanced | Median (range) | 13.6 (7.3–32.5) | 18.7 (14.4–24.9) | 12.6 (8–19.7) |
| Â | n | 28 | 8 | 7 |
BR + LA | Median (range) | 14.7 (10.6–47.2) | 26 (13–47.4) | 12.4 (8.8–17) |
| Â | n | 16 | 11 | 9 |
All patients | Median (range) | 15.3 (7.3–47.2) | 24.4 (11.7–47.4) | 11.5 (5.7–19.7) |
| Â | n | 63 | 39 | 32 |
Progression-free survival (months) | ||||
| Â | Â | All patients | Resected | Not resected |
Resectable | Median (range) | 8.4 (6.2–10.4) | 14.9 (8.4–23) | 11* |
| Â | n | 2 | 4 | 1 |
Borderline resectable | Median (range) | 9 (2.4–21.1) | 15.4 (4.7–23.2) | 2.1* |
| Â | n | 6 | 6 | 1 |
Locally advanced | Median (range) | 9.3 (4–17.6) | 12.9 (9.6–22.5) | 5.7 (4–8) |
| Â | n | 20 | 6 | 3 |
BR + LA | Median (range) | 9.9 (6.5–27.4) | 12.5 (9–19.7) | 7.5 (7.1–7.6) |
| Â | n | 9 | 4 | 2 |
All patients | Median (range) | 9.3 (2.4–27.4) | 12.9 (4.7–23.2) | 5.8 (2.1–11) |
| Â | n | 31 | 20 | 7 |